Mitchel Sayare - Sep 23, 2021 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ William Brown, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Sep 23, 2021
Transactions value $
$0
Form type
4
Date filed
9/24/2021, 08:47 PM
Next filing
Sep 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +24.1K $0.00 24.1K Sep 23, 2021 Common Stock, par value $0.0001 24.1K $15.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 23, 2021, subject to the reporting person's continued service through the applicable vesting date.